Sertindole, sold under the brand name Serdolect among others, is an antipsychotic medication. Sertindole was developed by the Danish pharmaceutical company Lundbeck and marketed …

舍吲哚是新开发的强效中枢性多巴胺D2和 5-羟色胺 （5-HT2） 受体拮抗剂，是 非典型抗精神病药物。 密闭，避光保存。 本品是苯吲哚衍生物，对5-HT2A和5-HT2C受体及多巴胺-D2受体 …

Sertindole is a second-generation antipsychotic recently reintroduced in the market for the treatment of schizophrenia after a reevaluation of its risks and benefits. 4 Our aim in this …

Sertindole is an atypical antipsychotic at least as effective as haloperidol and risperidone in the treatment of neuroleptic-responsive schizophrenia. Sertindole improves negative symptoms, …

舍吲哚是一种非典型抗精神病药，2002 年因其心脏毒性作用退出欧洲市场，2005 年又重新引入欧洲市场。 近期 Zoccali 博士、Bruno 博士及 Muscatello 博士在 Journal of Clinical …

舍吲哚片 （Sertindole），商品名 塞丁道尔。 精神分裂症。 本药品被归类到 精神分裂症 等药品分类。 本品对 运动神经 的 不良反应 （锥体外系 综合征），明显低于 氟哌啶醇，与 安慰剂 无 …

相比之下，位列第三、第四的帕利哌酮（Paliperidone，PAL）和舍吲哚（Sertindole，SER），其分析结果基于近年来的研究数据，与安慰剂相比，表现出中等效果（SMD -0.43，95%CI …

Sertindole is an atypical antipsychotic reintroduced into the European market in 2005 after a reevaluation of its risks and benefits, under the agreement that close electrocardiographic …

Sertindole is an atypical antipsychotic at least as effective as haloperidol and risperidone in the treatment of neuroleptic-responsive schizophrenia. Sertindole improves negative symptoms, …

Sertindole is an antipsychotic drug with affinity for dopamine D2, serotonin 5-HT2A and 5-HT2C, and alpha1-adrenoreceptors. Preclinical studies suggest that sertindole acts preferentially on …